Direct-to-consumer advertising of prescription medicines – evidence from the developing world?
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Presentation
- By: GRAY, Andy (University of KwaZulu-Natal, Nelson R Mandela School of Medicine, Congella, South Africa)
Although direct-to-consumer advertising (DTCA) of prescription medicines is legal in only two industrialised countries (New Zealand and the United States), the situation in developing countries is less easily described. Developing countries with effective medicines regulatory authorities may prohibit such practices, but in many countries there is.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.